← back to search

Nicholas Hobson

McMaster University · CA
Area of research
Neurology · Sociology and Political Science
Research interest
Research interests include Vascular Malformations Diagnosis and Treatment, Intracerebral and Subarachnoid Hemorrhage Research, Intracranial Aneurysms: Treatment and Complications, and Social and Intergroup Psychology.
h-index
23
citations
4,979
works
71
NIH funding
primary concept
email

Recent publications

Trial Readiness of Cavernous Malformations With Symptomatic Hemorrhage, Part II: Biomarkers and Trial Modeling
Stroke 2023cited by 13position: middledoi
PIK3CA and CCM mutations fuel cavernomas through a cancer-like mechanism
Nature 2021cited by 188position: middledoi
Astrocytes propel neurovascular dysfunction during cerebral cavernous malformation lesion formation
Journal of Clinical Investigation 2021cited by 59position: middledoi
Perfusion and Permeability<scp>MRI</scp>Predicts Future Cavernous Angioma Hemorrhage and Growth
Journal of Magnetic Resonance Imaging 2021cited by 14position: middledoi
Novel Murine Models of Cerebral Cavernous Malformations
Angiogenesis 2020cited by 51position: middledoi
Cerebral cavernous malformations are driven by ADAMTS5 proteolysis of versican
The Journal of Experimental Medicine 2020cited by 47position: middledoi
Propranolol inhibits cavernous vascular malformations by β1 adrenergic receptor antagonism in animal models
Journal of Clinical Investigation 2020cited by 43position: middledoi
A Roadmap for Developing Plasma Diagnostic and Prognostic Biomarkers of Cerebral Cavernous Angioma With Symptomatic Hemorrhage (CASH)
Neurosurgery 2020cited by 30position: middledoi
Distinct cellular roles for PDCD10 define a gut-brain axis in cerebral cavernous malformation
Science Translational Medicine 2019cited by 72position: middledoi
Rho Kinase Inhibition Blunts Lesion Development and Hemorrhage in Murine Models of Aggressive <i>Pdcd10/Ccm3</i> Disease
Stroke 2019cited by 57position: middledoi
A Brain-Targeted Orally Available ROCK2 Inhibitor Benefits Mild and Aggressive Cavernous Angioma Disease
Translational Stroke Research 2019cited by 38position: middledoi
Phantom validation of quantitative susceptibility and dynamic contrast‐enhanced permeability MR sequences across instruments and sites
Journal of Magnetic Resonance Imaging 2019cited by 15position: firstdoi
Atorvastatin Treatment of Cavernous Angiomas with Symptomatic Hemorrhage Exploratory Proof of Concept (AT CASH EPOC) Trial
Neurosurgery 2018cited by 86position: middledoi
Trial Readiness in Cavernous Angiomas With Symptomatic Hemorrhage (CASH)
Neurosurgery 2018cited by 44position: middledoi
Endothelial TLR4 and the microbiome drive cerebral cavernous malformations
Nature 2017cited by 298position: middledoi
Quantitative susceptibility mapping as a monitoring biomarker in cerebral cavernous malformations with recent hemorrhage
Journal of Magnetic Resonance Imaging 2017cited by 32position: middledoi
Vascular permeability and iron deposition biomarkers in longitudinal follow-up of cerebral cavernous malformations
Journal of neurosurgery 2016cited by 61position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Issam A. Awad · University of Chicago12 papers (2016–2021)Romuald Girard · Txcell (France)12 papers (2016–2021)Robert Shenkar · University of Chicago12 papers (2016–2021)Ying Cao · Nanjing Agricultural University9 papers (2016–2020)Rhonda Lightle · University of Chicago7 papers (2019–2021)Thomas Moore · Kent Hospital7 papers (2019–2021)Agnieszka Stadnik · University of Chicago6 papers (2017–2021)Timothy J. Carroll · University of Wisconsin–Madison5 papers (2017–2021)Janne Koskimäki · Oulu University Hospital5 papers (2018–2019)Douglas A. Marchuk · University of Virginia4 papers (2019–2020)Kelly D. Flemming · Mayo Clinic4 papers (2018–2020)Sean P. Polster · University of Illinois Chicago4 papers (2018–2019)Hussein A. Zeineddine · The University of Texas Health Science Center4 papers (2016–2018) · 4 papers (2019–2020)Gregory A. Christoforidis · Icahn School of Medicine at Mount Sinai4 papers (2016–2020)James I. Koenig · National Institutes of Health4 papers (2018–2020)Maged D Fam · Oasis Hospital3 papers (2016–2018)James K. Liao · University of Arizona3 papers (2018–2019)Nichol McBee · Johns Hopkins University3 papers (2017–2018)Daniel F. Hanley · Johns Hopkins University3 papers (2017–2018)